Table 2.
PCVa (%) | TS (g/dL) | Thrombocytopenia (N) (RI: 200‐500 K/μL)b | Neutrophilia (N)a (RI: 3.0‐12.0 K/μL) | Neutropenia (N) (RI: 3.0‐12.0 K/μL) | |
---|---|---|---|---|---|
Control Dogs (N = 40) | 47.70 ± 6.65 | 6.69 ± 0.49 | |||
Anemic Dogs (N = 40) |
22.78 ± 5.39 | 6.07 ± 1.30 |
N = 16 123 (84‐157) |
N = 15 19.4 (12.5‐62.2) |
N = 3 0.2 (0.0‐0.7) |
Hemolytic (N = 8) |
19.88 ± 4.09 | 6.99 ± 1.15 |
N = 4 123 (122‐124) |
N = 4 22.5 (13.1‐62.2) |
|
Neoplastic (N = 9) | 24.00 ± 5.48 | 5.52 ± 0.98 |
N = 5 120.5 (84‐157) |
N = 4 16.1 (12.5‐20.9) |
N = 1 0.2 |
Other (N = 23) |
23.42 ± 5.64 | 6.11 ± 1.42 |
N = 7 118 (93‐143) |
N = 7 15.5 (12.9‐46.7) |
N = 2 0.4 (0.0‐0.7) |
PCV and TS values represent the mean and standard deviation.
If significant platelet clumping was noted on blood smear analysis, total platelet number was estimated as decreased, adequate, or increased.
Platelet and neutrophil values represent the median and range.
Platelet counts were not available for all anemic patients.